Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Kitchener

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Vaccine|July 13, 2004
Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7)E J Davidson, R L Faulkner, P Sehr, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 30, 2006
The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinomaD D Rosa, A Clamp, S Mullamitha, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer centerR E Board, C T P H Bruijns, A E Pronk, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 13, 2016
Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UKL Khoja, K Nolan, R Mekki, et al.
Gynecologic Oncology|May 18, 2017
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiativeR J Edmondson, E J Crosbie, M Nickkho-Amiry, et al.
British Journal of Cancer|July 29, 2015
Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parametersM A Versluis, R A de Jong, A Plat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials GroupS B Kaye, J Paul, J Cassidy, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Vaccine|July 13, 2004
Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7)E J Davidson, R L Faulkner, P Sehr, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 30, 2006
The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinomaD D Rosa, A Clamp, S Mullamitha, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer centerR E Board, C T P H Bruijns, A E Pronk, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 13, 2016
Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UKL Khoja, K Nolan, R Mekki, et al.
Gynecologic Oncology|May 18, 2017
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiativeR J Edmondson, E J Crosbie, M Nickkho-Amiry, et al.
British Journal of Cancer|July 29, 2015
Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parametersM A Versluis, R A de Jong, A Plat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials GroupS B Kaye, J Paul, J Cassidy, et al.
Pageof 9